会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase
    • 苯基取代的三唑及其作为akl5激酶的选择性抑制剂的用途
    • US20050014938A1
    • 2005-01-20
    • US10495414
    • 2002-11-14
    • Laramie GasterJohn HarlingJag HeerThomas HeightmanAndrew Payne
    • Laramie GasterJohn HarlingJag HeerThomas HeightmanAndrew Payne
    • A61K31/4192A61K31/4196A61K31/433A61K31/538A61P1/00A61P1/04A61P1/16A61P3/12A61P9/10A61P11/00A61P13/12A61P19/00A61P19/02A61P19/10A61P25/00A61P25/28A61P27/02A61P43/00C07D249/06C07D265/36C07D285/14C07D403/04C07D413/04C07D417/04C07D471/04C07D417/02C07D413/02C07
    • C07D285/14C07D249/06C07D265/36C07D471/04
    • Phenyl substituted triazoles of formula (I) wherein R1 is naphthyl or phenyl optionally substituted with one or more substituents selected from halo, —O—C1-6alkyl, —S—C1-6alkyl, C1-6alkyl, C1-6haloalkyl, —O—(CH2)n-Ph, —S—(CH2)n-Ph, cyano, phenyl, and CO2R, wherein R is hydrogen or C1-6alkyl, and n is 0, 1, 2 or 3; or R1 is phenyl or pyridyl fused with an aromatic or non-aromatic cyclic ring of 5-7 members wherein said cyclic ring optionally contains up to three heteroatoms, independently selected from N, O and S, and N may be further optionally substituted by C1-6 alkyl, and wherein the cyclic ring may be optionally substituted by ═O; R2 and R3 are independently selected from H, C1-6alkyl, C1-6alkoxy, phenyl, NH(CH2)n-Ph, NH—C1-6alkyl, halo, alkoxy, CN, NO2, CONHR and SO2NHR; two of X1, X2 and X3 are N and the other is NR4 wherein R4 is hydrogen, C1-6alkyl, C3-7cycloalkyl, —(CH2)p—CN, —(CH2)p—CO2H, —(CH2)p—CONHR5R6, —(CH2)pCOR5, —(CH2)q(CR7)2, —(CH2)pOR5, (CH2)qCH═CH—CN, —(CH2)q—CH═CH—CO2H, —(CH2)p—CH═CH—CONHR5R6, —(CH2)pNHCOR8 or —(CH2)pNR9R10; R5 and R6 are independently hydrogen or C1-6alkyl; R7 is C1-6alkyl; R8 is C1-7alkyl, or optionally substituted aryl, heteroaryl, arylC1-6alkyl or heteroaryl C1-6alkyl; R9 and R10 are independently selected from hydrogen, C1-6alkyl, aryl and arylC1-6alkyl; p is 0-4; and q is 1-4 and salts and solvates thereof, are disclosed, as are methods for their preparation, pharmaceutical compositions containing them and their use in medicine.
    • 式(I)的苯基取代的三唑,其中R 1是萘基或任选被一个或多个选自卤素,-OC 1-6烷基,-S-C 1-6烷基,C 1-6烷基,C 1-6卤代烷基,-O- (CH 2)n-Ph,-S-(CH 2)n-Ph,氰基,苯基和CO 2 R,其中R是氢或C 1-6烷基,n是0,1,2或3; 或R 1是与5-7个成员的芳族或非芳族环的稠合的苯基或吡啶基,其中所述环任选地含有至多三个独立地选自N,O和S的杂原子,并且N可以进一步任选地被C1 -6烷基,并且其中所述环状环可以任选地被= O取代; R2和R3独立地选自H,C1-6烷基,C1-6烷氧基,苯基,NH(CH2)n-Ph,NH-C1-6烷基,卤素,烷氧基,CN,NO2,CONHR和SO2NHR; X1,X2和X3中的两个是N,另一个是NR4,其中R4是氢,C1-6烷基,C3-7环烷基, - (CH2)p-CN, - (CH2)p-CO2H, - (CH2)p-CONHR5R6 , - (CH2)pCOR5, - (CH2)q(CR7)2, - (CH2)pOR5,(CH2)qCH = CH-CN, - (CH2)q-CH = CH-CO2H, - (CH2) CH = CH-CONHR5R6, - (CH2)pNHCOR8或 - (CH2)p